| For: | Vilchez V, Turcios L, Marti F, Gedaly R. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol 2016; 22(2): 823-832 [PMID: 26811628 DOI: 10.3748/wjg.v22.i2.823] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i2/823.htm |
| Number | Citing Articles |
| 1 |
Kailun Ye, Chunhua Xu, Tongguan Hui. MiR-34b inhibits the proliferation and promotes apoptosis in colon cancer cells by targeting Wnt/β-catenin signaling pathway. Bioscience Reports 2019; 39(10) doi: 10.1042/BSR20191799
|
| 2 |
Shreya Sood, Shareen Singh, Thakur Gurjeet Singh. PCSK9 in bridging metabolism and neurodegeneration: a new paradigm for alzheimer’s treatment. Metabolic Brain Disease 2026; 41(1) doi: 10.1007/s11011-026-01900-1
|
| 3 |
Hyunjung Park, Hyerin Park, Jiyeon Baek, Hyuk Moon, Simon Weonsang Ro. Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. Biology 2022; 11(4) doi: 10.3390/biology11040585
|
| 4 |
Youmei Zhao, Chenglong Pan, Shu Yang, Xiaoling Ma, Yanfei Yao, Ziqi Li, Qianlin Ma, Xiaoyu Wang, Chunyan Wang, Zhi Nie. Research Progress of LEF1 Gene in Malignant Tumors. Clinical Medicine Insights: Oncology 2025; 19 doi: 10.1177/11795549251371111
|
| 5 |
Yongpan Lu, Dejie Zhao, Guoqi Cao, Siyuan Yin, Chunyan Liu, Ru Song, Jiaxu Ma, Rui Sun, Zhenjie Wu, Jian Liu, Peng Wu, Yibing Wang. Research progress on and molecular mechanism of vacuum sealing drainage in the treatment of diabetic foot ulcers. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1265360
|
| 6 |
Jing Feng, Jian Guo, Pengyu Zhao, Jing Shen, Baofeng Chai, Junping Wang. mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193815
|
| 7 |
Xiaoling Luo, Yuting Liu, Shijie Ma, Lei Liu, Rui Xie, Miaomiao Li, Peng Shen, Shaochuang Wang. STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells. Gene 2018; 662 doi: 10.1016/j.gene.2018.03.076
|
| 8 |
Fabrizio Montecucco, Davide Ramoni. MicroRNA-206 as a promising epigenetic approach to modulate tumor-associated macrophages in hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(41): 4503-4508 doi: 10.3748/wjg.v30.i41.4503
|
| 9 |
Melchiorre Cervello, Giuseppa Augello, Antonella Cusimano, Maria Rita Emma, Daniele Balasus, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma. Advances in Biological Regulation 2017; 65 doi: 10.1016/j.jbior.2017.06.002
|
| 10 |
Kai Teng, Shi Wei, Chi Zhang, Jiewei Chen, Jinbin Chen, Kanghua Xiao, Jun Liu, Miaomiao Dai, Xinyuan Guan, Jingping Yun, Dan Xie. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1331-8
|
| 11 |
Rainbow Wing Hei Leung, Terence Kin Wah Lee. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2022; 14(21) doi: 10.3390/cancers14215468
|
| 12 |
Ningjia Cao, Liang Mu, Wei Yang, Li Liu, Liang Liang, Hong Zhang. RETRACTED: MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling. Biomedicine & Pharmacotherapy 2018; 106 doi: 10.1016/j.biopha.2018.06.135
|
| 13 |
Bo Lin, Mengsen Li. Role of the Wnt/β-catenin signaling pathway in the development of HCC. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1691297
|
| 14 |
LILIANA PASLARU, PETRUTA ALEXANDRU, SANDA M. CRETOIU, SIMONA O. DIMA, IRINEL POPESCU. CRISPR/Cas9 gene editing in Huh7 and Hepa RG cell lines. Romanian Biotechnological Letters 2019; 24(2) doi: 10.25083/rbl/24.2/216.228
|
| 15 |
Jianwu Long, Longfei Liu, Xuefeng Yang, Xiaojun Zhou, Xianzhou Lu, Lei Qin. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway. Human Cell 2022; 36(1) doi: 10.1007/s13577-022-00802-5
|
| 16 |
Yidan Wang, Zhenting Zhang, Zhengyan Zhu, Peng Wang, Jinjuan Zhang, Hui Liu, Jianyu Li. The significance of EphA2-regulated Wnt/β-catenin signal pathway in promoting the metastasis of HBV-related hepatocellular carcinoma. Molecular Biology Reports 2023; 50(1) doi: 10.1007/s11033-022-08045-1
|
| 17 |
Nuobei Zhang, Xin Chen. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Cellular Oncology 2020; 43(1) doi: 10.1007/s13402-019-00478-4
|
| 18 |
Jianfang Dong, Lihua Li, Xuefei Zhang, Xijing Yin, Zucong Chen. CtBP2 Regulates Wnt Signal Through EGR1 to Influence the Proliferation and Apoptosis of DLBCL Cells. Molecular Carcinogenesis 2025; 64(6) doi: 10.1002/mc.23901
|
| 19 |
Muyao Zhang, Xing Wei, Zhenfei Wang. The mechanism of HBx protein to promote the initiation and progression of hepatocellular carcinoma. Infection International 2018; 7(1) doi: 10.2478/ii-2018-0010
|
| 20 |
Yubao Song, Xin Jin, Yong Liu, Shuiying Wang, Fang Bian, Qingqing Zhao, Hanping Shi, Zefeng Gao. Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis. Anti-Cancer Drugs 2021; 32(8) doi: 10.1097/CAD.0000000000001070
|
| 21 |
Jian Pu, Zuoming Xu, Jiahui Nian, Quan Fang, Meng Yang, Youguan Huang, Wenchuan Li, Bin Ge, Jianchu Wang, Huamei Wei. M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00556-3
|
| 22 |
Yagmur Yasar Firat, Betul Cicek, Ayca Kara, Nurefsan Konyaligil Ozturk, Selen Ilgun. Effects of Thyme, Cumin, and Sumac Extracts on Apoptosis and Paraptosis in Hepatocellular Carcinoma: Synergistic, Antagonistic, or Additive Properties. Food Science & Nutrition 2025; 13(4) doi: 10.1002/fsn3.70106
|
| 23 |
James M. Dolezal, Huabo Wang, Sucheta Kulkarni, Laura Jackson, Jie Lu, Sarangarajan Ranganathan, Eric S. Goetzman, Sivakama S. Bharathi, Kevin Beezhold, Craig A. Byersdorfer, Edward V. Prochownik. Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma. Journal of Biological Chemistry 2017; 292(24) doi: 10.1074/jbc.M117.782052
|
| 24 |
Dukhabandhu Naik, Sadishkumar Kamalanathan, Ayan Roy, Jayaprakash Sahoo, Samim A Mondal, Alpana Mukhuty, Somdatta Giri. Link between type 2 diabetes mellitus and hepatocellular carcinoma. World Journal of Hepatology 2025; 17(7): 107675 doi: 10.4254/wjh.v17.i7.107675
|
| 25 |
Ji‐Chang Fan, Fei Zeng, Yi‐Guan Le, Lin Xin. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR‐24‐3p. Journal of Cellular Biochemistry 2018; 119(8) doi: 10.1002/jcb.26479
|
| 26 |
Monu Kumar Kashyap, Sikma Roy, Shiwani Jaiswal, Shweta Verma, Siddharth Srivastava, Amit Kumar Nigam, Awadhesh Kumar, Bandana Singh, Ved Prakash Tiwari, Mahima Mahima, Akash Ved, Karuna S. Shukla, Namrata Singh. Recent Prospectives of Cellular Signaling Role for Mammary Gland Carcinogenesis. Anti-Cancer Agents in Medicinal Chemistry 2025; 25(12) doi: 10.2174/0118715206319933241104100736
|
| 27 |
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies. Therapeutic Advances in Medical Oncology 2018; 10 doi: 10.1177/1758835918816287
|
| 28 |
Ahrong Ham, Min Cho, Hye Won, Jungmin Jo, Kyoung Lee. β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells. Oncology Reports 2022; 48(1) doi: 10.3892/or.2022.8341
|
| 29 |
Wonhee Han, Hyeyoon Lee, Jin-Kwan Han. Ubiquitin C-terminal hydrolase37 regulates Tcf7 DNA binding for the activation of Wnt signalling. Scientific Reports 2017; 7(1) doi: 10.1038/srep42590
|
| 30 |
Wenqian Tang, Juan Xue, Lei Luo, Yao Wang, Xin Cai, Yuqing Liu, Dawei Huang, Xiaodong Wang, Tangqing He, Dingbo Lu, Fan Yang. Kangxianruangan granule‑containing serum mediated inhibition of hepatic oval cell differentiation into hepatocellular carcinoma cells via the Wnt‑1/β‑catenin signaling pathway. Molecular Medicine Reports 2021; 25(2) doi: 10.3892/mmr.2021.12571
|
| 31 |
Federico Selvaggi, Teresa Catalano, Roberto Cotellese, Gitana Maria Aceto. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents. Cancers 2022; 14(8) doi: 10.3390/cancers14081912
|
| 32 |
Linsong Tang, Shengjun Xu, Rongli Wei, Guanghan Fan, Junbin Zhou, Xuyong Wei, Xiao Xu. Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway. Molecular Medicine 2024; 30(1) doi: 10.1186/s10020-024-00878-9
|
| 33 |
Khaled Mahmoud, Mahmoud Teaima, Yasmeen Attia, Jingjing Sun, Mohamed El-Nabarawi, Shady Swidan. Reprogramming hepatocellular carcinoma: Nanomedicine at the crossroads of molecular targets and smart delivery. Colloids and Surfaces B: Biointerfaces 2026; 268 doi: 10.1016/j.colsurfb.2026.115981
|
| 34 |
Qingzheng Kang, Jun Gong, Mingfu Wang, Qiang Wang, Feng Chen, Ka-Wing Cheng. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling. Journal of Agricultural and Food Chemistry 2019; 67(50) doi: 10.1021/acs.jafc.9b05733
|
| 35 |
Zhi Liu, Yang Zhong, Yu Jian Chen, Hui Chen. SOX11 regulates apoptosis and cell cycle in hepatocellular carcinoma via Wnt/β‐catenin signaling pathway. Biotechnology and Applied Biochemistry 2019; 66(2) doi: 10.1002/bab.1718
|
| 36 |
S. Kondo, N. Yamamoto, Y. Katsuya, J. Sato, S. Mishima, A. Kawazoe, E. Oki, K. Yamazaki, S. Itoh, T. Yokota, S. Nagao, T. Kimura, S. Yamamuro, N. Hayata, T. Tamai, K. Shitara. E7386 in patients with advanced solid tumors: results from the dose-escalation part and an expansion part of a phase I study. ESMO Open 2025; 10(12) doi: 10.1016/j.esmoop.2025.105893
|
| 37 |
Baiyang Chen, Yang Gu, Hui Shen, Qiangsheng Liu, Hongbo Wang, Yabo Li, Xifan Liu, Yu Liu, Qinghao Du, Huapeng Sun, Xiaofeng Liao. Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S336452
|
| 38 |
Al Shaima G. Abd El Salam, Yara A. Samra, Mamdouh M. El-Shishtawy. Cinnamaldehyde Relieves Induced Hepatocellular Carcinoma in Rat Model via Targeting Wnt/β-Catenin Pathway. Scientia Pharmaceutica 2022; 90(2) doi: 10.3390/scipharm90020022
|
| 39 |
Pei‐song Bai, Nan Xia, Hong Sun, Ying Kong. Pleiotrophin, a target of miR‐384, promotes proliferation, metastasis and lipogenesis in HBV‐related hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2017; 21(11) doi: 10.1111/jcmm.13213
|
| 40 |
Jiahao Xue, Penglei Ge, Yang Wu. The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis. Clinical and Experimental Medicine 2022; 23(5) doi: 10.1007/s10238-022-00934-w
|
| 41 |
Rebecca Allen, Daneng Li. Oncology in the Precision Medicine Era. 2020; doi: 10.1007/978-3-030-31471-2_16
|
| 42 |
Shu Liu, Jiao Wang, Ting Shao, Peiying Song, Qingbin Kong, Hui Hua, Ting Luo, Yangfu Jiang. The natural agent rhein induces β‐catenin degradation and tumour growth arrest. Journal of Cellular and Molecular Medicine 2018; 22(1) doi: 10.1111/jcmm.13346
|
| 43 |
Chuanrui Xu, Zhong Xu, Yi Zhang, Matthias Evert, Diego F. Calvisi, Xin Chen. β-Catenin signaling in hepatocellular carcinoma. Journal of Clinical Investigation 2022; 132(4) doi: 10.1172/JCI154515
|
| 44 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12) doi: 10.3390/jcm6120111
|
| 45 |
Weidong Yuan, Hewei Zhao, Ang Zhou, Shaochuang Wang. Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2. Cancer Biology & Therapy 2022; 23(1) doi: 10.1080/15384047.2022.2149039
|
| 46 |
Chen Yang, Hailin Zhang, Linmeng Zhang, Andrew X. Zhu, René Bernards, Wenxin Qin, Cun Wang. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2023; 20(4) doi: 10.1038/s41575-022-00704-9
|
| 47 |
Zhi Chen, Na Cui, Ji-sen Zhao, Jian-fei Wu, Fang Ma, Cong Li, Xian-yi Liu. Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances. European Journal of Histochemistry 2021; 65(1) doi: 10.4081/ejh.2021.3173
|
| 48 |
Pengxiang Zhao, Yufei Li, Boyuan Guo, Ziyi Liu, Xujuan Zhang, Mengyu Liu, Xuemei Ma. Hydrogen-Releasing Micromaterial Dressings: Promoting Wound Healing by Modulating Extracellular Matrix Accumulation Through Wnt/β-Catenin and TGF-β/Smad Pathways. Pharmaceutics 2025; 17(3) doi: 10.3390/pharmaceutics17030279
|
| 49 |
Jing Peng, Xiangping Liu, Yan Mao, Meng Lv, Teng Ma, Jiaxiu Liu, Quan Zhou, Yafei Han, Xin Li, Haibo Wang. Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling. Molecular Carcinogenesis 2024; 63(8) doi: 10.1002/mc.23747
|
| 50 |
Guanyou Huang, Yujuan Wu, Yonggui Du, Hongchuan Gan, Shuyu Hao. Methyl-CpG Binding Protein 2 as a Potential Diagnostic and Prognostic Marker Facilitates Glioma Progression Through Activation of Wnt/β-Catenin Pathway. World Neurosurgery 2023; 171 doi: 10.1016/j.wneu.2022.12.063
|
| 51 |
Thomas J. Brown, Victoria James. The Role of Extracellular Vesicles in the Development of a Cancer Stem Cell Microenvironment Niche and Potential Therapeutic Targets: A Systematic Review. Cancers 2021; 13(10) doi: 10.3390/cancers13102435
|
| 52 |
Jiahong Wang, Jianping Liao, Ye Cheng, Meirong Chen, Aimin Huang. LAPTM4B enhances the stemness of CD133+ liver cancer stem-like cells via WNT/β-catenin signaling. JHEP Reports 2025; 7(4) doi: 10.1016/j.jhepr.2024.101306
|
| 53 |
Bhaskar Basu, Mrinal K. Ghosh. Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: Shifting gears at the molecular level. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022; 1869(7) doi: 10.1016/j.bbamcr.2022.119261
|
| 54 |
Fan Wu, Fang-Yong Zhang, Guo-Qian Tan, Wei-Jia Chen, Biao Huang, Lun Yan, Hao-Lu Zhang, Shi Chen, Yang Jiao, Bai-Lin Wang. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08327-0
|
| 55 |
Hanan M. Hassan, Sherif M H El-Kannishy, Abdullah Alattar, Reem Alshaman, Ahmed M Hamdan, Mohammed M H Al-Gayyar. Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion. Biomedicine & Pharmacotherapy 2021; 135 doi: 10.1016/j.biopha.2021.111216
|
| 56 |
Jayanta Das, Bhupen Barman, Phulen Sarma, Bipul Kumar Das, Rajiv Chetia, Partha Pratim Kalita. Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications. Biochemistry and Biophysics Reports 2026; 45 doi: 10.1016/j.bbrep.2025.102403
|
| 57 |
Jianbo Dai, Yaqin Hao, Xun Chen, Qingsan Yu, Bin Wang. miR‑122/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt/β‑catenin signaling. Oncology Letters 2023; 26(3) doi: 10.3892/ol.2023.13976
|
| 58 |
Chung-Ming Lin, Hsin-Han Chen, Chun-An Lin, Hui-Chung Wu, Jim Jinn-Chyuan Sheu, Hui-Jye Chen. Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00409-z
|
| 59 |
Beat Moeckli, Vaihere Delaune, Julien Prados, Matthieu Tihy, Andrea Peloso, Graziano Oldani, Thomas Delmi, Florence Slits, Quentin Gex, Laura Rubbia-Brandt, Nicolas Goossens, Stéphanie Lacotte, Christian Toso. Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model. Biomedicines 2022; 10(2) doi: 10.3390/biomedicines10020294
|
| 60 |
Sung Whan Cha, Joon Hyung Sohn, Sung Hoon Kim, Yun Tae Kim, Seong Hee Kang, Mee‐Yon Cho, Moon Young Kim, Soon Koo Baik. Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2020; 35(4) doi: 10.1111/jgh.14848
|
| 61 |
Mohammed Hawash, Nidal Jaradat, Murad Abualhasan, Johnny Amer, Serkan Levent, Shahd Issa, Sameeha Ibrahim, Aseel Ayaseh, Tahrir Shtayeh, Ahmed Mousa. Synthesis, chemo-informatics, and anticancer evaluation of fluorophenyl-isoxazole derivatives. Open Chemistry 2021; 19(1) doi: 10.1515/chem-2021-0078
|
| 62 |
Marhaba Nurmamat, Haili Yan, Ru Wang, Huixin Zhao, Yanhong Li, Xiaojing Wang, Kaidirye Nurmaimaiti, Tamasha Kurmanjiang, Difang Luo, Jumagul Baodi, Guancheng Xu, Jinyu Li. Novel Copper(II) Complex with a 4-Acylpyrazolone Derivative and Coligand Induce Apoptosis in Liver Cancer Cells. ACS Medicinal Chemistry Letters 2021; 12(3) doi: 10.1021/acsmedchemlett.0c00680
|
| 63 |
Haofei Kang, Weiwei Jiang. β-catenin ameliorates myocardial infarction by preventing YAP-associated apoptosis. Clinics 2023; 78 doi: 10.1016/j.clinsp.2023.100189
|
| 64 |
Kai-Ting Chuang, Li-Ting Wang, Shih-Hsien Hsu. Role of Wnt Ligand Secretion Mediator Signaling in Cancer Development. Journal of Cancer Research and Practice 2023; 10(1) doi: 10.4103/ejcrp.eJCRP-D-22-00029
|
| 65 |
Yang Ding, Yumei Ning, Hui Kang, Yuan Yuan, Kun Lin, Chun Wang, Yun Yi, Jianghua He, Lurao Li, Xingxing He, Ying Chang. ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway. Experimental Hematology & Oncology 2024; 13(1) doi: 10.1186/s40164-024-00475-w
|
| 66 |
Gesa von Olshausen, Maria Quasdorff, Romina Bester, Silke Arzberger, Chunkyu Ko, Maarten van de Klundert, Ke Zhang, Margarete Odenthal, Marc Ringelhan, Carien M. Niessen, Ulrike Protzer. Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion. Oncotarget 2018; 9(74) doi: 10.18632/oncotarget.26103
|
| 67 |
Fujing Xie, Lianhai Zhang, Qing Yao, Liyu Shan, Jike Liu, Nanhai Dong, Jun Liang. <p>TUG1 Promoted Tumor Progression by Sponging miR-335-5p and Regulating CXCR4-Mediated Infiltration of Pro-Tumor Immunocytes in CTNNB1-Mutated Hepatoblastoma</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S234819
|
| 68 |
Daolin Zeng, Chunlin Yu, Shiyao Chen, Long Zou, Junjun Chen, Linlong Xu. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03364-y
|
| 69 |
Béatrice Benoit, Christian Poüs. MAPping the Wnt pathway to hepatocellular carcinoma recurrence. Gut 2016; 65(9) doi: 10.1136/gutjnl-2016-311637
|
| 70 |
Ahmad Al‑Dali, Hans Weiher, Ingo Schmidt‑Wolf. Utilizing ethacrynic acid and ciclopirox olamine in liver cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.9472
|
| 71 |
Lei Zhang, Qing Zhang, Da Teng, Manyu Guo, Kechao Tang, Zhenglin Wang, Xiang Wei, Li Lin, Xiaomin Zhang, Xiuyun Wang, Dake Huang, Cuiping Ren, Qingsong Yang, Wenjun Zhang, Yong Gao, Wei Chen, Yongsheng Chang, Huabing Zhang. FGF9 Recruits β‐Catenin to Increase Hepatic ECM Synthesis and Promote NASH‐Driven HCC. Advanced Science 2023; 10(28) doi: 10.1002/advs.202301166
|
| 72 |
Xiaoyu Sun, Xuemei Lv, Yuanyuan Yan, Yanyun Zhao, Rong Ma, Miao He, Minjie Wei. Hypoxia-mediated cancer stem cell resistance and targeted therapy. Biomedicine & Pharmacotherapy 2020; 130 doi: 10.1016/j.biopha.2020.110623
|
| 73 |
Meng-Yu Wu, Giuo-Teng Yiang, Pei-Wen Cheng, Pei-Yi Chu, Chia-Jung Li. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy. Journal of Clinical Medicine 2018; 7(8) doi: 10.3390/jcm7080213
|
| 74 |
Hui Tang, Hui Zhao, Zhen-Yu Yu, Xiao Feng, Bin-Sheng Fu, Chun-Hui Qiu, Jian-Wen Zhang. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway. Digestive and Liver Disease 2019; 51(9) doi: 10.1016/j.dld.2019.02.012
|
| 75 |
Ulfa Kholili, Alvin Hartanto Kurniawan, Choirina Winda, Ummi Maimunah, Poernomo Budi Setiawan. The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma. Research Journal of Pharmacy and Technology 2023; doi: 10.52711/0974-360X.2023.00065
|
| 76 |
Long Guo, Zhihao Wang, Chengcheng Zhu, Jun Li, Luying Cui, Junsheng Dong, Xia Meng, Guoqiang Zhu, Jianji Li, Heng Wang. MCC950 inhibits the inflammatory response and excessive proliferation of canine corneal stromal cells induced by Staphylococcus pseudintermedius. Molecular Immunology 2022; 152 doi: 10.1016/j.molimm.2022.11.001
|
| 77 |
Abhay Dev Tripathi, Soumya Katiyar, Abha Mishra. Glypican1: A potential cancer biomarker for nanotargeted therapy. Drug Discovery Today 2023; 28(8) doi: 10.1016/j.drudis.2023.103660
|
| 78 |
Yang Jiao, Yan Wu, Dong Du. Polydatin inhibits cell proliferation, invasion and migration, and induces cell apoptosis in hepatocellular carcinoma. Brazilian Journal of Medical and Biological Research 2018; 51(4) doi: 10.1590/1414-431x20176867
|
| 79 |
Xun Zhang, Nazhen Dong, Xiaoyan Hu. Wnt/β-catenin Signaling Inhibitors. Current Topics in Medicinal Chemistry 2023; 23(10) doi: 10.2174/1568026623666230303101810
|
| 80 |
Kevin Delijani, Carolyn Hofley, Nancy Luo, George Yusin. Current Recommendations, Controversies, and Potential Novel Approaches in the Treatment of Wilms Tumor. Georgetown Medical Review 2020; 5(1) doi: 10.52504/001c.18059
|
| 81 |
Asmita Bhattacharya, Juncheng Wei, Wenxin Song, Beixue Gao, Chunyan Tian, Shuangcheng Alivia Wu, Jian Wang, Ligong Chen, Deyu Fang, Ling Qi. SEL1L-HRD1 ER-associated degradation suppresses hepatocyte hyperproliferation and liver cancer. iScience 2022; 25(10) doi: 10.1016/j.isci.2022.105183
|
| 82 |
Zongbing Guo, Yanmei Zhou, Jiping Yang, Xiaomei Shao. Dendrobium candidum extract inhibits proliferation and induces apoptosis of liver cancer cells by inactivating Wnt/β-catenin signaling pathway. Biomedicine & Pharmacotherapy 2019; 110 doi: 10.1016/j.biopha.2018.11.149
|
| 83 |
Bi‑Yun Zheng, Wen‑Yu Gao, Xiao‑Yun Huang, Li‑Ying Lin, Xue‑Fen Fang, Zhi‑Xin Chen, Xiao‑Zhong Wang. HBx promotes the proliferative ability of HL‑7702 cells via the COX‑2/Wnt/β‑catenin pathway. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8906
|
| 84 |
Yang Zhou, Xun Liu, Yahan Gao, Rulan Tan, Zhiyuan Wu, Qixin Zhong, Feng Zeng. Paeoniflorin Affects Hepatocellular Carcinoma Progression by Inhibiting Wnt/β-Catenin Pathway through Downregulation of 5-HT1D. Current Pharmaceutical Biotechnology 2021; 22(9) doi: 10.2174/1389201021666201009153808
|
| 85 |
Wenhui Wang, Lei Xu, Pengyu Liu, Kiran Jairam, Yuebang Yin, Kan Chen, Dave Sprengers, Maikel P. Peppelenbosch, Qiuwei Pan, Ron Smits. Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling. Neoplasia 2016; 18(12) doi: 10.1016/j.neo.2016.10.004
|
| 86 |
Liang Duan, Qianfan Yang, Jun Yang, Qin Hu, Bo Wang, Pu Li, Weixian Chen. Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1645-x
|
| 87 |
Jafar Ai, Neda Ketabchi, Javad Verdi, Nematollah Gheibi, Hossein Khadem Haghighian, Maria Kavianpour. Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1038-0
|
| 88 |
A-Rum Yoon, JinWoo Hong, Yan Li, Ha Chul Shin, Hyunah Lee, Hyun Soo Kim, Chae-Ok Yun. Mesenchymal Stem Cell–Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma. Cancer Research 2019; 79(17) doi: 10.1158/0008-5472.CAN-18-3900
|
| 89 |
Hong-Yi Lin, Ah-Jung Jeon, Kaina Chen, Chang Jie Mick Lee, Lingyan Wu, Shay-Lee Chong, Chukwuemeka George Anene-Nzelu, Roger Sik-Yin Foo, Pierce Kah-Hoe Chow. The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics. British Journal of Cancer 2025; 132(10) doi: 10.1038/s41416-025-02969-8
|
| 90 |
Takahiro Fukazawa, Keiji Tanimoto, Emi Yamaoka, Masato Kojima, Masami Kanawa, Nobuyuki Hirohashi, Eiso Hiyama. Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy. Cancers 2022; 14(19) doi: 10.3390/cancers14194732
|
| 91 |
Ke Luo, Xiuhui Gu, Jing Liu, Guodan Zeng, Liaotian Peng, Houyi Huang, Mengju Jiang, Ping Yang, Minhui Li, Yuhan Yang, Yuanyuan Wang, Quekun Peng, Li Zhu, Kun Zhang. Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling. Experimental Cell Research 2016; 347(1) doi: 10.1016/j.yexcr.2016.07.014
|
| 92 |
Mohamed N. Amin, Yousra M. El-Far, Mohammed El-Mowafy, Abdelaziz Elgaml. Tazemetostat decreases β-catenin and CD13 protein expression in HEPG-2 and Hepatitis B virus-transfected HEPG-2 with decreased cell viability. Clinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01593-8
|
| 93 |
Lei Du, Lina Wang, Hong Yang, Jianping Duan, Jianming Lai, Wei Wu, Shaohua Fan, Xiaoli Zhi. Sex Comb on Midleg Like-2 Accelerates Hepatocellular Carcinoma Cell Proliferation and Metastasis by Activating Wnt/β-Catenin/EMT Signaling. Yonsei Medical Journal 2021; 62(12) doi: 10.3349/ymj.2021.62.12.1073
|
| 94 |
Haoyu Tian, Peng Wang, Haibo Shao. Natural Bioactive Compounds Targeting the Wnt/β-Catenin Pathway for the Treatment of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2025; doi: 10.2147/JHC.S523261
|
| 95 |
Derya Erisik, Berrin Ozdil, Eda Acikgoz, Cemile Sinem Asker Abdikan, Taha Kadir Yesin, Huseyin Aktug. Differences and Similarities between Colorectal Cancer Cells and Colorectal Cancer Stem Cells: Molecular Insights and Implications. ACS Omega 2023; 8(33) doi: 10.1021/acsomega.3c02681
|
| 96 |
Shuang Shang, Fang Hua, Zhuo-Wei Hu. The regulation of β-catenin activity and function in cancer: therapeutic opportunities. Oncotarget 2017; 8(20) doi: 10.18632/oncotarget.15687
|
| 97 |
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail, Samy Y. Elkhawaga, Mahmoud A. Elrebehy, Ahmed S. Doghish. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathology - Research and Practice 2022; 233 doi: 10.1016/j.prp.2022.153886
|
| 98 |
Chunhua Song, Hongwei Li, Zhengchun Huang, Xinfeng Chang, Wen Pan, Zhihua Zhang. Matrine inhibits cell proliferation, invasion, and stem cell formation in hepatocellular carcinoma by regulating the ELAVL1/RBM3‐mediated Wnt/β‐catenin signaling pathway. Chemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14442
|
| 99 |
Gitana Maria Aceto, Roberto Cotellese, Rossano Lattanzio, Teresa Catalano, Federico Selvaggi. Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities. World Journal of Gastroenterology 2023; 29(18): 2764-2783 doi: 10.3748/wjg.v29.i18.2764
|
| 100 |
Rongcai Yue, Haiping Liu, Yaxin Huang, Jing Wang, Dongmei Shi, Yanping Su, Yufei Luo, Ping Cai, Guilin Jin, Changxi Yu. Sempervirine Inhibits Proliferation and Promotes Apoptosis by Regulating Wnt/β-Catenin Pathway in Human Hepatocellular Carcinoma. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.806091
|
| 101 |
Baiyang Chen, Jianwei Lan, Yusha Xiao, Pengpeng Liu, Deliang Guo, Yang Gu, Youai Song, Qiu Zhong, Dong Ma, Ping Lei, Quanyan Liu. Long noncoding RNA TP53TG1 suppresses the growth and metastasis of hepatocellular carcinoma by regulating the PRDX4/β-catenin pathway. Cancer Letters 2021; 513 doi: 10.1016/j.canlet.2021.04.022
|
| 102 |
Li Zhang, Bin Qin, Baicang Zou, Shenhao Wang, Xiaojing Quan, Jinhai Wang, Hongli Zhao. Knockdown of TRIM15 inhibits the proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inactivation of the Wnt/β-catenin signaling pathway. Journal of Bioenergetics and Biomembranes 2021; 53(2) doi: 10.1007/s10863-021-09872-w
|
| 103 |
Betül Akçeşme, Florina Abazi, Adna Hrapovic, Selma Kozaric. Investigation of phytochemicals derived from Gentiana dinarica as potential drug candidates for colorectal cancer by computational approaches. Hacettepe Journal of Biology and Chemistry 2025; 54(1) doi: 10.15671/hjbc.1712451
|
| 104 |
Linlin Qu, Wenjuan Yang, Yingcong Huang, Di Zhi, Bin Zhu, Xiaoxuan Ma, Daidi Fan. Ginsenoside Rh4 regulates the PPARγ/WNT/β-catenin/Warburg axis through activation of PGC1α to inhibit tumor growth and metastasis in a primary hepatocellular carcinoma mouse model. Journal of Future Foods 2025; doi: 10.1016/j.jfutfo.2025.05.021
|
| 105 |
Hui Zhang, Xun Li, Wenbo Meng, Lei Zhang, Xiaoliang Zhu, Zhongtian Bai, Jun Yan, Wence Zhou. Overexpression of p16ink4a regulates the Wnt/β‑catenin signaling pathway in pancreatic cancer cells. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8139
|
| 106 |
Wei Zeng, Fang Wang, Yu Ma, Xianchun Liang, Ping Chen. Dysfunctional Mechanism of Liver Cancer Mediated by Transcription Factor and Non-coding RNA. Current Bioinformatics 2019; 14(2) doi: 10.2174/1574893614666181119121916
|
| 107 |
Yaguang Qin, Hong Lu. In vitro evaluation of anti-hepatoma activity of brevilin A: involvement of Stat3/Snail and Wnt/β-catenin pathways. RSC Advances 2019; 9(8) doi: 10.1039/C8RA08574A
|
| 108 |
Kuo-Shyang Jeng, Chiung-Fang Chang, I-Shyang Sheen, Chi-Juei Jeng, Chih-Hsuan Wang. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(2) doi: 10.3390/ijms24021417
|
| 109 |
Ivana Samaržija. Wnt Signaling Pathway Is among the Drivers of Liver Metastasis. Livers 2021; 1(4) doi: 10.3390/livers1040015
|
| 110 |
Wanhu Fan, Fenjing Du, Xiaojing Liu. Phosphatidylinositol 4-phosphate adaptor protein 2 accelerates the proliferation and invasion of hepatocellular carcinoma cells by enhancing Wnt/β-catenin signaling. Journal of Bioenergetics and Biomembranes 2020; 52(5) doi: 10.1007/s10863-020-09852-6
|
| 111 |
Junyi Jin, Yihui Wang, Yaoyuan Hu. STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β‐catenin signaling pathway. Molecular Carcinogenesis 2024; 63(11) doi: 10.1002/mc.23801
|
| 112 |
Ruohan Zhao, Jinhai Luo, Baojun Xu. Insights into secondary metabolites and health promoting effects of edible flower Hemerocallis citrina Baroni. Journal of Functional Foods 2024; 116 doi: 10.1016/j.jff.2024.106133
|
| 113 |
Yasmin H. Habiba, Gamal A. Omran, Maged W. Helmy, Maha E. Houssen. Antitumor effects of rhamnazinon sorafenib-treated human hepatocellular carcinoma cell lines via modulation of VEGF signaling and PI3K/NF-κB p38/caspase-3 axes cross talk. Life Sciences 2022; 297 doi: 10.1016/j.lfs.2022.120443
|
| 114 |
Ce Li, Wenming Li, Shengda Cao, Jianing Xu, Ye Qian, Xinliang Pan, Dapeng Lei, Dongmin Wei. Circ_0058106 promotes proliferation, metastasis and EMT process by regulating Wnt2b/β-catenin/c-Myc pathway through miR-185-3p in hypopharyngeal squamous cell carcinoma. Cell Death & Disease 2021; 12(11) doi: 10.1038/s41419-021-04346-8
|
| 115 |
Bin Chen, Lana Garmire, Diego F. Calvisi, Mei-Sze Chua, Robin K. Kelley, Xin Chen. Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2020; 17(4) doi: 10.1038/s41575-019-0240-9
|
| 116 |
Chinmay Das, Chanakya Nath Kundu. Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects. Critical Reviews in Microbiology 2025; 51(6) doi: 10.1080/1040841X.2025.2461045
|
| 117 |
Pengyu Wang, Xitong Yang, Dan Liu, Yunhui Yang, Yuanyuan Zhang, Guangming Wang. Construction of a competing endogenous RNA network to analyse glucose-6-phosphate dehydrogenase dysregulation in hepatocellular carcinoma. Bioscience Reports 2022; 42(6) doi: 10.1042/BSR20220674
|
| 118 |
Yun Liu, Hao Zhuang, Fang Cao, Jie Li, Yan Guo, Jun Zhang, Qiang Zhao, Yuanyuan Liu. Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway. Cell Death & Disease 2021; 12(3) doi: 10.1038/s41419-021-03560-8
|
| 119 |
Dina Mofed, Salwa Sabet, Ahmed A. Baiomy, Tamer Z. Salem. The Transgene Expression of the Immature Form of the HCV Core Protein (C191) and the LncRNA MEG3 Increases Apoptosis in HepG2 Cells. Current Issues in Molecular Biology 2022; 44(8) doi: 10.3390/cimb44080249
|
| 120 |
Yihua Yang, Yan Jiang, Man Jiang, Jiamiao Zhang, Bing Yang, Yuanping She, Wanxue Wang, Yan Deng, Yuan Ye. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma. Experimental and Molecular Pathology 2016; 100(2) doi: 10.1016/j.yexmp.2016.03.002
|
| 121 |
Ayatollah A. El-Shorbagy, Medhat W. Shafaa, Rasha Salah Elbeltagy, Rehab E. El-Hennamy, Soad Nady. Liposomal IL-22 ameliorates liver fibrosis through miR-let7a/STAT3 signaling in mice. International Immunopharmacology 2023; 124 doi: 10.1016/j.intimp.2023.111015
|
| 122 |
Liyan Wang, Bin Li, Xiaoyuan Yi, Xuhua Xiao, Qinghua Zheng, Lei Ma. Circ_0036412 affects the proliferation and cell cycle of hepatocellular carcinoma via hedgehog signaling pathway. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03305-x
|
| 123 |
Yihao Xing, Yile Hu, Hanzhi Zou, Huaxia Xie, Tianci Jiang, Ling Liu. A novel O2- (2,4-dinitrophenyl) diazeniumdiolate inhibits hepatocellular carcinoma migration, invasion, and EMT through the Wnt/β-catenin pathway. Toxicology in Vitro 2022; 84 doi: 10.1016/j.tiv.2022.105456
|
| 124 |
Zhengyao Xie, Zhiyan Dai, Ziyao Liu, Yiqiang Chen, Shuting Huang, Siyuan Liu, Jingjing Li, Jie Shen. The impact of an RNA-binding protein group on regulating the RSPO-LGR4/5-ZNRF3/RNF43 module and the immune microenvironment in hepatocellular carcinoma. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13874-x
|
| 125 |
Sonia Ben Hamouda, Khadija Essafi-Benkhadir. Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer. International Journal of Molecular Sciences 2023; 24(6) doi: 10.3390/ijms24065600
|
| 126 |
Ye Liu, Di Huang, Zhaoyang Wang, Chao Wu, Zhao Zhang, Dan Wang, Zongjin Li, Tianhui Zhu, Shuang Yang, Wei Sun. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep36050
|
| 127 |
Valeria Lucarini, Daniela Nardozi, Valentina Angiolini, Monica Benvenuto, Chiara Focaccetti, Raffaele Carrano, Zein Mersini Besharat, Roberto Bei, Laura Masuelli. Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion. Biomedicines 2023; 11(6) doi: 10.3390/biomedicines11061761
|
| 128 |
Osama M. Ahmed, Sanaa R. Galaly, Mennah-Allah M. A. Mostafa, Emad M. Eed, Tarek M. Ali, Alzhraa M. Fahmy, Mohamed Y. Zaky, Lei Chen. [Retracted] Thyme Oil and Thymol Counter Doxorubicin‐Induced Hepatotoxicity via Modulation of Inflammation, Apoptosis, and Oxidative Stress. Oxidative Medicine and Cellular Longevity 2022; 2022(1) doi: 10.1155/2022/6702773
|
| 129 |
Guijuan Yu, Yang Liu, Jihong Dai, Weihao Ou, Qinghui Ai, Wenbing Zhang, Kangsen Mai, Yanjiao Zhang.
Dietary daidzein improves the development of intestine subjected to soybean meal in juvenile turbot (
Scophthalmus maximus
L.)
. Aquaculture Nutrition 2021; 27(1) doi: 10.1111/anu.13161
|
| 130 |
Rahul Kumar Vempati, Rama Rao Malla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00012-4
|
| 131 |
Bo Li, Yu‐Zhen Ge, Wei‐Wei Yan, Bin Gong, Kun Cao, Rui Zhao, Chao Li, Ye‐Wei Zhang, Yi‐Heng Jiang, Shi Zuo. DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β‐catenin to promote its ubiquitin degradation pathway. Cell Proliferation 2022; 55(9) doi: 10.1111/cpr.13273
|
| 132 |
Lingfei Tong, Wenming Wu. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways. Pathology - Research and Practice 2019; 215(9) doi: 10.1016/j.prp.2019.152522
|
| 133 |
Bada Yoon, Rajaghatta N. Suresh, Chakrabhavi Dhananjaya Mohan, Kachigere B. Harsha, C.S. Shivakumara, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Gautam Sethi, Kanchugarakoppal S. Rangappa, Kwang Seok Ahn. Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells. Archives of Biochemistry and Biophysics 2025; 770 doi: 10.1016/j.abb.2025.110476
|
| 134 |
Jianzhou Cui, Han-Ming Shen, Lina Hsiu Kim Lim. The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets. Pharmaceuticals 2020; 13(12) doi: 10.3390/ph13120432
|
| 135 |
Maite G Fernández-Barrena, Maria J Perugorria, Jesus M Banales. Novel lncRNA T-UCR as a potential downstream driver of the Wnt/β-catenin pathway in hepatobiliary carcinogenesis. Gut 2017; 66(7) doi: 10.1136/gutjnl-2016-312899
|
| 136 |
Xin Qing, Wenjing Xu, Jingjing Zong, Xuanlong Du, Hao Peng, Yewei Zhang. Emerging treatment modalities for systemic therapy in hepatocellular carcinoma. Biomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00319-3
|
| 137 |
N. P. Belyak, A. V. Androsova. Typical metastases, atypical course of the disease and morphology. Clinical Case in Oncology 2024; 1(1) doi: 10.62546/3034-1477-2023-1-1-63-73
|
| 138 |
Feng Feng, Aiping Chen, Junjian Huang, Qinghua Xia, Yougen Chen, Xunbo Jin. Retracted: Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR‐98/STAT3/Wnt/β‐catenin pathway axis. Journal of Cellular Biochemistry 2018; 119(11) doi: 10.1002/jcb.27257
|
| 139 |
T. R. Jeffry Evans, Natalie Cook, Anthony El-Khoueiry, David J. Pinato, Nguyen H. Tran, David Hsiehchen, Edward Mena, Tim Meyer, Jincao Wu, Shriram M. Pathak, Costanza Paoletti, Lea Dutta, Chinyere E. Okpara, Juanita S. Lopez. A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms. British Journal of Cancer 2026; doi: 10.1038/s41416-026-03488-w
|
| 140 |
Shixiong Lei, Xilin Du, Kai Tan, Xiaojun He, Yejing Zhu, Shoujie Zhao, Zhenyu Yang, Gang Dou. CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling. Experimental and Therapeutic Medicine 2023; 26(1) doi: 10.3892/etm.2023.12013
|
| 141 |
Jiachen Zheng, Ming Zhao, Jiahui Li, Guoying Lou, Yanyan Yuan, Shizhong Bu, Yang Xi. Obesity-associated digestive cancers: A review of mechanisms and interventions. Tumor Biology 2017; 39(3) doi: 10.1177/1010428317695020
|
| 142 |
Wei-Juan Huang, Xiao-Peng Tian, Si-Xue Bi, Si-Rui Zhang, Ting-Sha He, Li-Yan Song, Jing-Ping Yun, Zhong-Guo Zhou, Rong-Min Yu, Mei Li. The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis. Oncogene 2020; 39(23) doi: 10.1038/s41388-020-1307-3
|
| 143 |
Melek Pehlivan, Ceyda Caliskan, Zeynep Yuce, Hakkı Ogun Sercan. Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors. Tumor Biology 2017; 39(5) doi: 10.1177/1010428317701654
|
| 144 |
Yi Shi, Jingrui Men, Hongliang Sun, Jianjun Tan. The Identification and Analysis of MicroRNAs Combined Biomarkers for
Hepatocellular Carcinoma Diagnosis. Medicinal Chemistry 2022; 18(10) doi: 10.2174/1573406418666220404084532
|
| 145 |
Haiyan Fan, Meng Zhang, Wei Liu. Hypermethylated KCNQ1 acts as a tumor suppressor in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2018; 503(4) doi: 10.1016/j.bbrc.2018.08.099
|
| 146 |
Bang-li Hu, Cheng Shi, Rong-e Lei, Dong-hong Lu, Wei Luo, Shan-yu Qin, You Zhou, Hai-xing Jiang. Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin. Scientific Reports 2016; 6(1) doi: 10.1038/srep36436
|
| 147 |
Elisavet Lioulia, Panagiotis Mokos, Emmanuel Panteris, Dimitra Dafou. UBE2T promotes β‐catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK‐dependent activation. Molecular Oncology 2022; 16(8) doi: 10.1002/1878-0261.13111
|
| 148 |
Georgios Tsoulfas, Ioannis A Ziogas. Evolving role of Sorafenib in the management of hepatocellular carcinoma. World Journal of Clinical Oncology 2017; 8(3): 203-213 doi: 10.5306/wjco.v8.i3.203
|
| 149 |
Sebastian Winkler, Ivana Winkler, Mirjam Figaschewski, Thorsten Tiede, Alfred Nordheim, Oliver Kohlbacher. De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-04670-6
|
| 150 |
Chu-lan Xiao, Zhi-peng Zhong, Can Lü, Bing-jie Guo, Jiao-jiao Chen, Tong Zhao, Zi-fei Yin, Bai Li. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway. Journal of Integrative Medicine 2023; 21(2) doi: 10.1016/j.joim.2023.01.002
|
| 151 |
Xiao-Ying Jiang, Li Wang, Zong-Yin Liu, Wen-Xia Song, Mi Zhou, Lan Xi. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway. Journal of Receptors and Signal Transduction 2021; 41(4) doi: 10.1080/10799893.2020.1813761
|
| 152 |
Bingling Guo, Chunyan Xiao, Yumin Liu, Ning Zhang, Hao Bai, Tao Yang, Ying Xiang, Yingyu Nan, Qiying Li, Wenjun Zhang, Dehong Huang. miR-744-5p Inhibits Multiple Myeloma Proliferation, Epithelial Mesenchymal Transformation and Glycolysis by Targeting SOX12/Wnt/β-Catenin Signaling. OncoTargets and Therapy 2021; doi: 10.2147/OTT.S270636
|
| 153 |
Bin-bin Zhao, Zhi-hua Ye, Xiang Gao, Han-min Li. Diwu Yanggan Modulates the Wnt/β-catenin Pathway and Inhibits Liver Carcinogenesis Signaling in 2-AAF/PH Model Rats. Current Medical Science 2019; 39(6) doi: 10.1007/s11596-019-2123-2
|
| 154 |
Simone Patergnani, Donald J. Buchsbaum, Gary A. Piazza. Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1022174
|
| 155 |
Yan Yang, Jianlin Pu, You Yang. Glycolysis and chemoresistance in acute myeloid leukemia. Heliyon 2024; 10(15) doi: 10.1016/j.heliyon.2024.e35721
|
| 156 |
Xia Cheng, Dandan Liu, Xinxin Ren, You Nie, Yibing Zhao, Ruyu Chen, Hongwei Wang. The β-catenin/CBP signaling axis participates in sepsis-induced inflammatory lung injury. Experimental Biology and Medicine 2022; 247(17) doi: 10.1177/15353702221097316
|
| 157 |
Faezeh Hosseinzadeh, Tahereh Komeili movahhed, Masoumeh Dolati, Amir Hossein Kheirkhah, Nima Beheshtizadeh, Javad Verdi. Assessment of the main signaling pathways involved in the combined therapy of hepatocellular carcinoma using Sorafenib and NK cells in xenograft mice model. Toxicology Reports 2025; 15 doi: 10.1016/j.toxrep.2025.102131
|
| 158 |
Jiong Jiang, Bing Xu, Ying Zheng, Xiaoyan Guo, Fenrong Chen. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling. Experimental Cell Research 2020; 395(1) doi: 10.1016/j.yexcr.2020.112181
|
| 159 |
Munmun Panda, Bijesh K. Biswal. Cell signaling and cancer: a mechanistic insight into drug resistance. Molecular Biology Reports 2019; 46(5) doi: 10.1007/s11033-019-04958-6
|
| 160 |
Xiaolong Tang, Yahang Liang, Guorui Sun, Qingsi He, Hui Qu, Peng Gao. UBQLN4 is activated by C/EBPβ and exerts oncogenic effects on colorectal cancer via the Wnt/β-catenin signaling pathway. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00795-4
|
| 161 |
Kaveh Baghaei, Nazanin Hosseinkhan, Hamid Asadzadeh Aghdaei, M R Zali. Investigation of a common gene expression signature in gastrointestinal cancers using systems biology approaches. Molecular BioSystems 2017; 13(11) doi: 10.1039/C7MB00450H
|
| 162 |
So-Young Chun, Kyung-Soo Nam, Kyu-Shik Lee. Proton Beam Induces P53-mediated Cell Cycle Arrest in HepG2 Hepatocellular Carcinoma Cells. Biotechnology and Bioprocess Engineering 2020; 25(2) doi: 10.1007/s12257-019-0390-1
|
| 163 |
Tianyu Li, Xue Xiong, Yujing Wang, Yue Li, Yao Liu, Mingxiu Zhang, Chao Li, Tong Yu, Wei Cao, Shuangshuang Chen, Huizhen Zhang, Xiaona Wang, Lifang Lv, Yuhong Zhou, Haihai Liang, Xuelian Li, Hongli Shan. Neuroepithelial cell-transforming 1 promotes cardiac fibrosis via the Wnt/β-catenin signaling pathway. iScience 2023; 26(10) doi: 10.1016/j.isci.2023.107888
|
| 164 |
Ruhi Dixit, Manoj Pandey, Sunil Kumar Tripathi, Amit Nandan Dhar Dwivedi, Vijay Kumar Shukla. Genetic mutational analysis of β-catenin gene affecting GSK-3β phosphorylation plays a role in gallbladder carcinogenesis: Results from a case control study. Cancer Treatment and Research Communications 2020; 23 doi: 10.1016/j.ctarc.2020.100173
|
| 165 |
Chia‐Jui Yen, Yu‐Lin Ai, Hung‐Wen Tsai, Shih‐Huang Chan, Chia‐Sheng Yen, Kuang‐Hsiung Cheng, Yun‐Ping Lee, Chia‐Wei Kao, Yu‐Chun Wang, Yi‐Lin Chen, Cheng‐Han Lin, Tsunglin Liu, Huey‐Pin Tsai, Jen‐Ren Wang, Ih‐Jen Su, Wenya Huang. Hepatitis B virus surface gene pre‐S2 mutant as a high‐risk serum marker for hepatoma recurrence after curative hepatic resection. Hepatology 2018; 68(3) doi: 10.1002/hep.29790
|
| 166 |
Khalid Imtiyaz, Mohsin Shafi, Khalid Umar Fakhri, Laraib Uroog, Bushra Zeya, Syed Tauqeer Anwer, M Moshahid Alam Rizvi. Polydatin: A natural compound with multifaceted anticancer properties. Journal of Traditional and Complementary Medicine 2025; 15(5) doi: 10.1016/j.jtcme.2024.06.006
|
| 167 |
Qian Li, Dan-Lei Xiong, Heng Wang, Wei-Li Jin, Ying-Yu Ma, Xiao-Ming Fan. High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma. OncoTargets and Therapy 2021; doi: 10.2147/OTT.S296187
|
| 168 |
Mehran Piran, Neda Sepahi, Afagh Moattari, Amir Rahimi, Ali Ghanbariasad. Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential Therapeutic Targets. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.597536
|
| 169 |
Shaohua Zeng, Baoyi Zhu, Jun Zeng, Wenqi Wu, Chonghe Jiang. Zeylenone represses the progress of human prostate cancer by downregulating the Wnt/β‑catenin pathway. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9564
|
| 170 |
Kazuhiko Yamada, Yusaku Hori, Satoshi Inoue, Yuji Yamamoto, Kentaro Iso, Hiroshi Kamiyama, Atsumi Yamaguchi, Takayuki Kimura, Mai Uesugi, Junichi Ito, Masahiro Matsuki, Kazutaka Nakamoto, Hitoshi Harada, Naoki Yoneda, Atsushi Takemura, Ikuo Kushida, Naomi Wakayama, Kenji Kubara, Yu Kato, Taro Semba, Akira Yokoi, Masayuki Matsukura, Takenao Odagami, Masao Iwata, Akihiko Tsuruoka, Toshimitsu Uenaka, Junji Matsui, Tomohiro Matsushima, Kenichi Nomoto, Hiroyuki Kouji, Takashi Owa, Yasuhiro Funahashi, Yoichi Ozawa. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling. Cancer Research 2021; 81(4) doi: 10.1158/0008-5472.CAN-20-0782
|
| 171 |
Amit Kumar Tripathi, Anup Kumar Ray, Sunil Kumar Mishra. Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials. Beni-Suef University Journal of Basic and Applied Sciences 2022; 11(1) doi: 10.1186/s43088-022-00196-1
|
| 172 |
Romina Mancinelli, Guido Carpino, Simonetta Petrungaro, Caterina Loredana Mammola, Luana Tomaipitinca, Antonio Filippini, Antonio Facchiano, Elio Ziparo, Claudia Giampietri, Maria C. Albertini. Multifaceted Roles of GSK‐3 in Cancer and Autophagy‐Related Diseases. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/4629495
|
| 173 |
Hameis M. Sleem, Aya A. Ali, Eman Ramadan. Cisplatin palbociclib combination differentially modulates PTEN AKT signaling via Hsp90 in hepatocellular carcinoma cells. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-04008-1
|
| 174 |
Kurt Sartorius, Julia Makarova, Benn Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019; 8(12) doi: 10.3390/cells8121504
|
| 175 |
So-Young Chun, Soyoung Kim, Kyung-Soo Nam, Kyu-Shik Lee. Anti-metastatic potential of a proton beam is regulated by p38 MAPK/c-Fos signaling pathway in TPA-treated HepG2 human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2018; 99 doi: 10.1016/j.biopha.2018.01.134
|
| 176 |
Yan Sun, Hai Sun. Retracted:Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5. Journal of Cellular Physiology 2020; 235(3) doi: 10.1002/jcp.29202
|
| 177 |
Wenlong Hu, Jie Shen, Yu Tao, Dan Dong, Sicheng Lu, Liu Li, Dongdong Sun, Minmin Fan, Changliang Xu, Weixing Shen, Chengtao Yu, Haibo Cheng. CCDC85C suppresses colorectal cancer cells proliferation and metastasis through activating GSK-3β and promoting β-catenin degradation. Cellular Signalling 2023; 109 doi: 10.1016/j.cellsig.2023.110799
|
| 178 |
Jinze Shen, Qurui Wang, Qinyuan Huang, Xiaowei Ying, Zehua Wang, Zhengfeng Xu, Jingyin Dong, Shiwei Duan. Recent Insights Into Wnt‐Related tRNA‐Derived Fragments (tRFs) in Human Diseases. Journal of Cellular Biochemistry 2025; 126(1) doi: 10.1002/jcb.30702
|
| 179 |
Nermin M. Mohamed, Rania Hassan Mohamed, John F. Kennedy, Mahmoud M. Elhefnawi, Nadia M. Hamdy. A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. International Journal of Biological Macromolecules 2025; 311 doi: 10.1016/j.ijbiomac.2025.143616
|
| 180 |
Elham Amjad, Solmaz Asnaashari, Ali Jahanban-Esfahlan, Babak Sokouti. The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature. Biochemistry and Biophysics Reports 2024; 37 doi: 10.1016/j.bbrep.2023.101606
|
| 181 |
Haleema Azam, Lisa Pierro, Martina Reina, William M Gallagher, Maria Prencipe. Emerging role for the Serum Response Factor (SRF) as a potential therapeutic target in cancer. Expert Opinion on Therapeutic Targets 2022; 26(2) doi: 10.1080/14728222.2022.2032652
|
| 182 |
J. Bornschein, S. Schlosser, A. G. Schreyer, M. Müller-Schilling. Das hepatozelluläre Karzinom. Der Gastroenterologe 2016; 11(5) doi: 10.1007/s11377-016-0101-9
|
| 183 |
Jing Zhen, Kailin Jiao, Keke Yang, Maoxuan Wu, Qian Zhou, Bingmo Yang, Wei Xiao, Chunyan Hu, Ming Zhou, Zhong Li. The 14-3-3η/GSK-3β/β-catenin complex regulates EndMT induced by 27-hydroxycholesterol in HUVECs and promotes the migration of breast cancer cells. Cell Biology and Toxicology 2021; 37(4) doi: 10.1007/s10565-020-09564-y
|
| 184 |
David Prince, Ken Liu, Weiqi Xu, Minjiang Chen, Jin-Yu Sun, Xiao-Jie Lu, Jiansong Ji. Management of patients with intermediate stage hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920970840
|
| 185 |
Smriti Verma, Bidya Dhar Sahu, Madhav Nilakanth Mugale. Role of lncRNAs in hepatocellular carcinoma. Life Sciences 2023; 325 doi: 10.1016/j.lfs.2023.121751
|
| 186 |
Li Chen, Ning Hu, Chao Wang, Hongmian Zhao. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells. Archives of Biochemistry and Biophysics 2020; 680 doi: 10.1016/j.abb.2019.108244
|
| 187 |
Lingling Zhang, Ran Ren, Xue Yang, Yiman Ge, Xiajun Zhang, Hongping Yuan. Oncogenic role of early growth response-1 in liver cancer through the regulation of the microRNA-675/sestrin 3 and the Wnt/β-catenin signaling pathway. Bioengineered 2021; 12(1) doi: 10.1080/21655979.2021.1964889
|
| 188 |
Pritam Das, Tithi Bhattacharyya, Aasia Ansari, Anjaneyulu Eanti, Yogesh Chandra, Rajkumar Banerjee. Glucocorticoid receptor-targeted liposomal delivery of wnt/β-catenin pathway inhibitor selectively induces efficient colorectal tumor regression. Drug Delivery and Translational Research 2026; 16(5) doi: 10.1007/s13346-025-01952-3
|
| 189 |
Baharan Fekry, Aleix Ribas-Latre, Corrine Baumgartner, Alaa M.T. Mohamed, Mikhail G. Kolonin, Frances M. Sladek, Mamoun Younes, Kristin L. Eckel-Mahan. HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. Cancer Research 2019; 79(22) doi: 10.1158/0008-5472.CAN-19-1277
|
| 190 |
Xiaoli Zhang, Na Li, Ying Zhu, Wei Wen. The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma. Cancer Medicine 2022; 11(4) doi: 10.1002/cam4.4521
|
| 191 |
Ruizhen Wu, Bingqing Zhao, Xunxin Ren, Shiheng Wu, Mingzao Liu, Zipeng Wang, Wei Liu. <p>MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway</p>. Cancer Management and Research 2020; doi: 10.2147/CMAR.S255419
|
| 192 |
Rory P. Cunningham, Sun Woo Sophie Kang, Natalie Porat-Shliom. Location matters: cellular heterogeneity in the hepatic lobule and hepatocellular carcinoma. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 324(4) doi: 10.1152/ajpgi.00278.2022
|
| 193 |
Gang Zhao, Yahua Song, Lei Dong, Haitao Shi, Hong Li, Longbao Yang, Jinhai Wang. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling. Biochemical and Biophysical Research Communications 2019; 517(4) doi: 10.1016/j.bbrc.2019.07.122
|
| 194 |
Fang Yuan, Qian Gao, Hailin Tang, Jun Shi, Yiqun Zhou. Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways. Molecular Medicine Reports 2022; 25(4) doi: 10.3892/mmr.2022.12638
|
| 195 |
Peikun Li, Zhongshan Yu, Liang He, Dachen Zhou, Shengxue Xie, Hui Hou, Xiaoping Geng. Knockdown of FOXK1 inhibited the proliferation, migration and invasion in hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 2017; 92 doi: 10.1016/j.biopha.2017.05.087
|
| 196 |
Na Fu, Su-Xian Zhao, Ling-Bo Kong, Jing-Hua Du, Wei-Guang Ren, Fang Han, Qing-Shan Zhang, Wen-Cong Li, Po Cui, Rong-Qi Wang, Yu-Guo Zhang, Yue-Min Nan. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis. Gene 2017; 618 doi: 10.1016/j.gene.2017.03.008
|
| 197 |
Jose J.G. Marin, Marta R. Romero, Elisa Herraez, Maitane Asensio, Sara Ortiz-Rivero, Anabel Sanchez-Martin, Luca Fabris, Oscar Briz. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems. Seminars in Liver Disease 2022; 42(01) doi: 10.1055/s-0041-1735631
|
| 198 |
Dustin J. Flanagan, Elizabeth Vincan, Toby J. Phesse. Wnt Signaling in Cancer: Not a Binary ON:OFF Switch. Cancer Research 2019; 79(23) doi: 10.1158/0008-5472.CAN-19-1362
|
| 199 |
Jing Shen, Wenpeng Cai, Yongfang Ma, Ruyue Xu, Zhen Huo, Li Song, Xinyin Qiu, Yinci Zhang, Amin Li, Weiya Cao, Shuping Zhou, Xiaolong Tang. hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway. Nanoscale Research Letters 2020; 15(1) doi: 10.1186/s11671-020-03451-5
|
| 200 |
Yulia I. Nussbaum, Jeffrey N. Bryan, Guangfu Li, Alana Rodney, William T. N. Culp, Peter J. Dickinson, Anna Koutoulas, Kate Megquier, Hong An, Skyler T. Kramer, Edward S. Ricemeyer, Jonathan B. Mitchem, Wesley C. Warren. Comparative multi-omics evaluation of the tumor microenvironment in dog and human hepatocellular carcinoma. Veterinary Oncology 2025; 2(1) doi: 10.1186/s44356-025-00037-0
|
| 201 |
Xuan Huang, Jing Tang. Human La Protein: An RNA-Binding Protein Involved in Ovarian Cancer Development and Multidrug Resistance. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S269983
|
| 202 |
Dayun Yang, Wensong Luo, Jichuang Wang, Min Zheng, Xin-Hua Liao, Nan Zhang, Wenxian Lu, Long Wang, Ai-Zheng Chen, Wen-Guo Wu, Hekun Liu, Shi-Bin Wang, Xiao Zhen Zhou, Kun Ping Lu. A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways. Journal of Controlled Release 2018; 269 doi: 10.1016/j.jconrel.2017.11.031
|
| 203 |
Manasi Kotulkar, Diego Paine-Cabrera, Udayan Apte. Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer. Seminars in Liver Disease 2024; 44(03) doi: 10.1055/a-2349-7236
|
| 204 |
Jianqi Qin, Weixiong Zhu, Wence Zhou. Navigating the Paradox of IL‐22: Friend or Foe in Hepatic Health?. Journal of Gastroenterology and Hepatology 2025; 40(6) doi: 10.1111/jgh.16991
|
| 205 |
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01924-w
|
| 206 |
|
| 207 |
Xiaoling Luo, Yuting Liu, Shijie Ma, Lei Liu, Rui Xie, Shaochuang Wang. WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2019; 64(9) doi: 10.1007/s10620-019-05583-w
|
| 208 |
Nattpawit Kaewnoonual, Arunporn Itharat, Suriya Pongsawat, Cheng Nilbu‑Nga, Vichununt Kerdput, Wisuit Pradidarcheep. Anti‑angiogenic and anti‑proliferative effects of Benja‑ummarit extract in rats with hepatocellular carcinoma. Biomedical Reports 2020; doi: 10.3892/br.2020.1272
|
| 209 |
Ye Shi, Weiming Cui, Lei Xi, Feng Liu, Zicheng Liu, Jie Jiang, Zhengcheng Liu, Hui Cao. Silencing of ZNF610 suppresses cell proliferation and migration in lung adenocarcinoma. Cell Biochemistry and Function 2024; 42(4) doi: 10.1002/cbf.4078
|
| 210 |
Shuang-Peng Cai, Xiao-Yu Cheng, Pei-Jie Chen, Xue-Yin Pan, Tao Xu, Cheng Huang, Xiao-Ming Meng, Jun Li. Transmembrane protein 88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells. Molecular Immunology 2016; 80 doi: 10.1016/j.molimm.2016.11.002
|
| 211 |
Lian‐Hui Wei, Yan Dong, Yu‐Feng Sun, Xue‐Song Mei, Xue‐Song Ma, Jie Shi, Qing‐li Yang, Yan‐Ru Ji, Zheng‐Hai Zhang, Hu‐Nan Sun, Xing‐Rong Sun, Shu‐Min Song. Anticancer property of Hemp Bioactive Peptides in Hep3B liver cancer cells through Akt/GSK3β/β‐catenin signaling pathway. Food Science & Nutrition 2021; 9(4) doi: 10.1002/fsn3.1976
|
| 212 |
Shuang Luo, Lu Gan, Yiqun Luo, Zhikun Zhang, Lan Li, Huixue Wang, Tong Li, Qiaoying Chen, Yong Huang, Jian He, Liping Zhong, Xiuli Liu, Pan Wu, Yong Wang, Yongxiang Zhao, Zhenghan Zhang. Application of Molecular Nanoprobes in the Analysis of Differentially Expressed Genes and Prognostic Models of Primary Hepatocellular Carcinoma. Journal of Biomedical Nanotechnology 2021; 17(6) doi: 10.1166/jbn.2021.3098
|
| 213 |
Tanja Jesenko, Simona Kranjc Brezar, Maja Cemazar, Alice Biasin, Domenico Tierno, Bruna Scaggiante, Mario Grassi, Chiara Grassi, Barbara Dapas, Nhung Hai Truong, Michela Abrami, Fabrizio Zanconati, Deborah Bonazza, Flavio Rizzolio, Salvatore Parisi, Giorgia Pastorin, Gabriele Grassi. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. Pharmaceutics 2023; 15(4) doi: 10.3390/pharmaceutics15041249
|
| 214 |
Joseph Torresi, Bang Manh Tran, Dale Christiansen, Linda Earnest-Silveira, Renate Hilda Marianne Schwab, Elizabeth Vincan. HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5916-6
|
| 215 |
Pia Kronschnabl, Arnold Gr�nweller, Roland Hartmann, Achim Aigner, Ulrike Weirauch. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in�vitro and in�vivo primarily through the modulation of cell cycle progression. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4936
|
| 216 |
Yuanyuan Li, Yang Yu, Lei Yang, Rui Wang. Insights into the Role of Oxidative Stress in Hepatocellular Carcinoma Development. Frontiers in Bioscience-Landmark 2023; 28(11) doi: 10.31083/j.fbl2811286
|
| 217 |
Yingying Zhu, Yajing He, Runliang Gan. Wnt Signaling in Hepatocellular Carcinoma: Biological Mechanisms and Therapeutic Opportunities. Cells 2024; 13(23) doi: 10.3390/cells13231990
|
| 218 |
Chih‑Jan Ko, Chia‑Jung Li, Meng‑Yu Wu, Pei‑Yi Chu. Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6794
|
| 219 |
Yarong Guo, Jun Xu, Qiang Du, Yihe Yan, David A. Geller. IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin. Translational Oncology 2021; 14(6) doi: 10.1016/j.tranon.2021.101059
|
| 220 |
Hung Huynh, Richard Ong, Kah Yong Goh, Liek Yeow Lee, Florian Puehler, Arne Scholz, Oliver Politz, Dominik Mumberg, Karl Ziegelbauer. Sorafenib/MEK inhibitor combination inhibits tumor growth and the Wnt/β‑catenin pathway in xenograft models of hepatocellular carcinoma. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4693
|
| 221 |
Asmita Bhattacharya, Juncheng Wei, Wenxin Song, Beixue Gao, Chunyan Tian, Jian Wang, Ligong Chen, Deyu Fang, Ling Qi. Sel1L-Hrd1 ER-Associated Degradation Suppresses Hepatocyte Hyperproliferation and Liver Cancer. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4104809
|
| 222 |
E. Zacksenhaus, J.C. Liu, Z. Jiang, Y. Yao, L. Xia, M. Shrestha, Y. Ben-David. Chromatin Proteins and Transcription Factors as Therapeutic Targets. Advances in Protein Chemistry and Structural Biology 2017; 107 doi: 10.1016/bs.apcsb.2016.10.003
|
| 223 |
Junling Huang, Senping Huang, Guangzhi Li, Guiliu Huang, Zansong Huang, Shixiang Su, Tengmeng Zhong. RETRACTED: Structure and expression of FAPP2 protein in hepatocellular carcinoma: Its effect and molecular mechanism on HepG2 and MHCC97H in clinical treatment. International Journal of Biological Macromolecules 2025; 290 doi: 10.1016/j.ijbiomac.2024.139073
|
| 224 |
Yu-Yun Shao, Han-Yu Wang, Hung-Wei Hsu, Rita Robin Wo, Ann-Lii Cheng, Chih-Hung Hsu. Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma. Biology Direct 2025; 20(1) doi: 10.1186/s13062-025-00645-8
|
| 225 |
Yara A. Samra, Al Shaima G. Abd El Salam, Amr M. Abdelghany, Mamdouh M. El-Shishtawy. Safranal-loaded gold nanoparticles alleviate hepatocellular carcinoma via targeting the Wnt/β-catenin pathway. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02447-w
|
| 226 |
Yagmur Azbazdar, Yeliz Demirci, Guillaume Heger, Dogac Ipekgil, Mustafa Karabicici, Gunes Ozhan. Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth. Molecular Oncology 2023; 17(11) doi: 10.1002/1878-0261.13520
|
| 227 |
Xiao-Hua Jiang, Yu-Tao Xie, Ya-Ping Cai, Jing Ren, Tao Ma. Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway. BMC Microbiology 2017; 17(1) doi: 10.1186/s12866-017-1032-4
|
| 228 |
Hwa-Yong Lee, In-Sun Hong. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer. Cancers 2020; 12(10) doi: 10.3390/cancers12102746
|
| 229 |
Wei Yuan, Xinxin Zeng, Bin Chen, Sihan Yin, Jing Peng, Xiong Wang, Xingxing Yuan, Kewei Sun. Bisdemethoxycurcumin suppresses liver fibrosis-associated hepatocellular carcinoma via inhibiting CXCL12-induced macrophage polarization. Chinese Journal of Natural Medicines 2025; 23(10) doi: 10.1016/S1875-5364(25)60871-5
|
| 230 |
Kebinuer Tuerxun, Shufang Zhang, Yuexin Zhang. Downregulation of PITX2 inhibits the proliferation and migration of liver cancer cells and induces cell apoptosis. Open Life Sciences 2021; 16(1) doi: 10.1515/biol-2021-0133
|
| 231 |
Youming Ding, Xiaoyan Chen, Bin Wang, Bin Yu, Jianhui Ge. Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells. European Journal of Pharmacology 2018; 825 doi: 10.1016/j.ejphar.2018.02.020
|
| 232 |
Xiaoting Luo, Xin He, Xingmei Zhang, Xiaohui Zhao, Yuzhe Zhang, Yusheng Shi, Shengni Hua. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy. MedComm 2024; 5(2) doi: 10.1002/mco2.474
|
| 233 |
Shuang Cao, Sihan Yu, Liangbin Huang, Samuel Seery, Yu Xia, Yongwei Zhao, Zhongzhou Si, Xinxue Zhang, Jiqiao Zhu, Ren Lang, Jiantao Kou, Haiming Zhang, Lin Wei, Guangpeng Zhou, Liying Sun, Lei Wang, Ting Li, Qiang He, Zhijun Zhu. Deep learning for hepatocellular carcinoma recurrence before and after liver transplantation: a multicenter cohort study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-91728-z
|
| 234 |
Jing Li, Shusheng Wang, Chastain Anderson, Fangkun Zhao, Yu Qin, Di Wu, Xinwei Wu, Jia Liu, Xuefei He, Jiangyue Zhao, Jinsong Zhang, Tudor C Badea. Requirement of Smad4 from Ocular Surface Ectoderm for Retinal Development. PLOS ONE 2016; 11(8) doi: 10.1371/journal.pone.0159639
|
| 235 |
Liang-yun Li, Jun-fa Yang, Fan Rong, Zhi-pan Luo, Shuang Hu, Hui Fang, Ying Wu, Rui Yao, Wei-hao Kong, Xiao-wen Feng, Bang-jie Chen, Jun Li, Tao Xu. ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway. Acta Pharmacologica Sinica 2021; 42(10) doi: 10.1038/s41401-020-00575-3
|
| 236 |
Xiaoqiang Gao, Xiaodong Jia, Moyan Xu, Jiao Xiang, Jin Lei, Yinyin Li, Yinying Lu, Shi Zuo. Regulation of Gamma-Aminobutyric Acid Transaminase Expression and Its Clinical Significance in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.879810
|
| 237 |
Zhen Cai, Zhen-Yu Qian, Hao Jiang, Ning Ma, Zhi Li, Li-Yu Liu, Xin-Xin Ren, Yu-Rong Shang, Jing-Jing Wang, Jing-Jing Li, Dong-Ping Liu, Xiu-Ping Zhang, Dan Feng, Qian-Zhi Ni, Yuan-Yuan Feng, Nan Li, Xiao-Yan Zhou, Xiang Wang, Ying Bao, Xue-Li Zhang, Yue-Zhen Deng, Dong Xie. hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling. Cancer Research 2018; 78(10) doi: 10.1158/0008-5472.CAN-17-0028
|
| 238 |
Yumei Bai, Yanghua Li, Juan Bai, Yumei Zhang. Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis. Journal of Orthopaedic Surgery and Research 2021; 16(1) doi: 10.1186/s13018-021-02631-y
|
| 239 |
Priyadarshini Mohapatra, Natarajan Chandrasekaran. Wnt/β-catenin targeting in liver carcinoma through nanotechnology-based drug repurposing: A review. Biomedicine & Pharmacotherapy 2022; 155 doi: 10.1016/j.biopha.2022.113713
|
| 240 |
Dongdong Zhou, Dandan Chen, Jingwan Wu, Ting Feng, Pinghuai Liu, Jing Xu. Dicerandrol C Suppresses Proliferation and Induces Apoptosis of HepG2 and Hela Cancer Cells by Inhibiting Wnt/β-Catenin Signaling Pathway. Marine Drugs 2024; 22(6) doi: 10.3390/md22060278
|
| 241 |
Chang Liu, Yi-jun Tu, Hong-Yang Cai, Yan-yan Pan, Yuan-yuan Wu, Li Zhang. Regulatory T cells inhibit FoxP3 to increase the population of tumor initiating cells in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2024; 150(7) doi: 10.1007/s00432-024-05892-2
|
| 242 |
Fayyaz Rasool, Binayak Kumar, Deepu Sharma, Sri Krishna Jayadev Magani. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00006-5
|
| 243 |
Haili Lang, Renjie Xiao, Ying Li, Jing Sun, Yong Chen, Yimei Lu, Junying Cai. Linc-FOXD3 knockdown enhances hippocampal NSCs activation through upregulation of the Wnt/β-catenin pathway. Neuroscience Letters 2020; 729 doi: 10.1016/j.neulet.2020.134991
|
| 244 |
Jia-Hong Liang, Qiao-Dong Xu, Song-Gang Gu. LncRNA RSU1P2-microRNA let-7a-Testis-Expressed Protein 10 axis modulates tumorigenesis and cancer stem cell-like properties in liver cancer. Bioengineered 2022; 13(2) doi: 10.1080/21655979.2022.2031394
|
| 245 |
Doaa Ali Abdelmonsif, Ahmed S. Sultan, Wessam F. El-Hadidy, Dina Mohamed Abdallah. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. Molecular Diagnosis & Therapy 2018; 22(1) doi: 10.1007/s40291-017-0307-7
|
| 246 |
Tao Song, Ke Ma, Cui Zhao, Jijin Yang, Jingyu Liu. MicroRNA‑2053 overexpression inhibits the development and progression of hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10501
|
| 247 |
Amira Isaac, Sherif Mounir Mohamed, Osama Ashraf Ahmed, Ahmed Gamal Mohamed Hassan, Hany Samir Rasmy. Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment. The Egyptian Journal of Internal Medicine 2021; 33(1) doi: 10.1186/s43162-021-00078-5
|
| 248 |
Teresa Catalano, Federico Selvaggi, Diana Liberata Esposito, Roberto Cotellese, Gitana Maria Aceto. Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. Microorganisms 2023; 11(7) doi: 10.3390/microorganisms11071632
|
| 249 |
Sang‐Kyu Lee, Woo‐Jeong Jeong, Yong‐Hee Cho, Pu‐Hyeon Cha, Jeong‐Su Yoon, Eun Ji Ro, Sooho Choi, Jeong‐Min Oh, Yunseok Heo, Hyuntae Kim, Do Sik Min, Gyoonhee Han, Weontae Lee, Kang‐Yell Choi. β‐Catenin‐RAS interaction serves as a molecular switch for RAS degradation via GSK3β. The EMBO Reports 2018; 19(12) doi: 10.15252/embr.201846060
|
| 250 |
Chang'an Zhao, Liping Mo, Chao Li, Shuiping Han, Wenbo Zhao, Lifeng Liu. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway. Molecular and Cellular Endocrinology 2020; 515 doi: 10.1016/j.mce.2020.110925
|
| 251 |
Izabela Zarębska, Arkadiusz Gzil, Justyna Durślewicz, Damian Jaworski, Paulina Antosik, Navid Ahmadi, Marta Smolińska-Świtała, Dariusz Grzanka, Łukasz Szylberg. The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers. Clinics and Research in Hepatology and Gastroenterology 2021; 45(3) doi: 10.1016/j.clinre.2021.101664
|
| 252 |
Huanan Kang, Yiming Sun, Xijiao Hu, Li Liu. Gigantol inhibits proliferation and enhanced oxidative stress‐mediated apoptosis through modulating of Wnt/β‐catenin signaling pathway in HeLa cells. Journal of Biochemical and Molecular Toxicology 2022; 36(1) doi: 10.1002/jbt.22944
|
| 253 |
Chih‐Li Chen, Yu‐Shuen Tsai, Yen‐Hua Huang, Yuh‐Jin Liang, Ya‐Yun Sun, Chien‐Wei Su, Gar‐Yang Chau, Yi‐Chen Yeh, Yung‐Sheng Chang, Jui‐Ting Hu, Jaw‐Ching Wu. Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial‐Mesenchymal Transition Regulators and Stemness Genes. Hepatology Communications 2018; 2(11) doi: 10.1002/hep4.1229
|
| 254 |
Binyong Liang, Haichuan Wang, Yu Qiao, Xue Wang, Manning Qian, Xinhua Song, Yi Zhou, Yi Zhang, Runze Shang, Li Che, Yifa Chen, Zhiyong Huang, Hong Wu, Satdarshan P. Monga, Yong Zeng, Diego F. Calvisi, Xiaoping Chen, Xin Chen. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation‐driven hepatocarcinogenesis. Hepatology 2023; 77(6) doi: 10.1002/hep.32693
|